drugset / Trial / NCT01472315

Postmenopausal Women,Treatment of Sleep Apnea and Co-morbidities

NCT01472315

Phase 2/3 Completed 34 enrolled Turku University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

The purposes of this study are to evaluate the degree and duration of medroxyprogesterone acetate effect as well as tolerability in postmenopausal women with nasal continuous positive airway pressure (CPAP) treated sleep apnea and to compare the effects with nasal CPAP.

Timeline

Start
2000-01
Primary completion
2000-11
Completion
2000-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator medroxyprogesterone acetate Other / unclassified 60 mg

Indications